Author Health
Maggie Sherrill is an accomplished principal product manager currently leading initiatives at Author Health since December 2023. Previously, at Cureatr from April 2022 to November 2023, Maggie focused on enhancing clinical service performance across virtual telehealth programs, delivering significant improvements in patient engagement and operational efficiency. Experienced in product management and program oversight, additional roles include senior product manager at Cureatr, product manager at Wellframe, and product owner at InterSystems. Maggie also has a solid foundation in project engineering, with early roles at athenahealth and SRA. Maggie holds a Master of Science in Health Informatics from Northeastern University and a Bachelor of Arts in Biology from the University of Virginia.
This person is not in any teams
This person is not in any offices
Author Health
1 followers
Author Health is the first platform to provide comprehensive care and treatment for Medicare Advantage recipients with serious mental illness (SMI) and substance use disorders (SUD). Author Health offers a team-based approach to care, bringing together specialized physicians, nurses, therapists, and community health workers to deliver a mix of virtual and in-person care for individuals who are often disconnected from the traditional healthcare system. This approach overcomes workforce shortages in behavioral health fields and geographic barriers to care, and blends excellent medical treatment with the foundation of behavior change: relationships. Through this model, patients and their caregivers are given an avenue to reconnect with healthcare providers and receive personalized and comprehensive treatment outside of institutions and in their communities. Led by some of the nation’s foremost leaders in healthcare administration, behavioral health, and integrated care, the company launched from stealth in 2023 with $115 million in financing led by General Atlantic with participation from Flare Capital Partners. Author Health is currently serving patients in Florida and Texas, with nationwide coverage coming soon.